Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
5
Number of overlapping holdings
17.9%
% of PBE's 28 holdings also in IDNA
10.9%
% of IDNA's 51 holdings also in PBE
Overlap by Weight
Sector Drift (PBE minus IDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PBE |
Weight in IDNA |
Overlap | |
|---|---|---|---|---|
 |
REGENERON PHARMACEUTICALS | 4.5% | 3.9% | 3.9% |
|
EXELIXIS INC | 2.8% | 4.9% | 2.8% |
|
BIOCRYST PHARMACEUTICALS INC | 2.7% | 2.4% | 2.4% |
|
INCYTE CORP | 2.3% | 3.8% | 2.3% |
|
XENCOR INC | 2.2% | 1.2% | 1.2% |
Position Highlights (Non-Overlapping Exposures)
PBE Overweight Relative to IDNA
|
GILEAD SCIENCES INC | 5.1% |
|
NEUROCRINE BIOSCIENCES INC | 5.0% |
|
AMGEN INC | 5.0% |
|
BIOGEN IDEC INC | 5.0% |
|
NATERA INC | 4.7% |
|
UNITED THERAPEUTICS CORP | 4.4% |
|
ILLUMINA INC | 4.3% |
|
PROTAGONIST THERAPEUTICS, INC. | 3.9% |
|
TG THERAPEUTICS INC | 3.8% |
|
CATALYST PHARMACEUTICAL PART | 3.3% |
PBE Underweight Relative to IDNA
 |
BEIGENE, LTD. | -6.2% |
 |
ROCHE HOLDING LTD | -5.5% |
 |
SANOFI-AVENTIS | -5.4% |
 |
GSK PLC | -5.3% |
|
ASTRAZENECA PLC | -5.1% |
|
SPRINGWORKS THERAPEUTICS, INC. | -5.0% |
 |
TAKEDA PHARMACEUTICAL CO LTD | -4.9% |
 |
GENMAB A/S | -4.3% |
|
MERCK & CO. INC. | -4.1% |
|
ARCELLX, INC. | -3.8% |